Skip to content

Clinical trials

Cystic Fibrosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Country / region: France Clear all

244 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20051
20063
20072
20089
200912
20109
20117
201216
20138
201414
201523
201616
201718
201813
201916
20209
202119
202211
20239
202418
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed156
Terminated29
Unknown status28
Recruiting20
Active, not recruiting7
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated32
Assistance Publique - Hôpitaux de Paris30
Hospices Civils de Lyon28
University Hospital, Montpellier16
University Hospital, Brest9
University Hospital, Strasbourg, France8
University Hospital, Bordeaux7
Boehringer Ingelheim6
PTC Therapeutics6
University Hospital, Tours6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis244
Lung Diseases8
Pseudomonas Infections7
Pulmonary Disease, Chronic Obstructive6
Asthma5
Diabetes Mellitus4
Fibrosis4
Respiratory Tract Infections4
Anxiety Disorders3
Bronchiectasis3

Trials

Showing 51 to 75 of 244. Each trial links to its page on Pharma Observatory.

144 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.